Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1 Multiple endocrine neoplasia type 1 (MENI) is an autosomal dominant disease characterised by hyperplasia or neoplasia of the parathyroids, anterior pituitary, and the endocrine pancreas.' Other associated features, such as asymptomatic adrenal neoplasia, thyroid nodules, carcinoid tumours, lipomas, and pinealomas, have been reported at a much lower frequency.2 The age of presentation can range from early teens to late fifties. To date, only a few MENI related thymic carcinoids have been described. In the largest reported MENI family,3 four affected males were found to have metastatic thymic carcinoids but none of the patients was I 3 lll 1121 3n~~~4n immediately related. 4 One malignant and one benign case were reported in a kindred of German extraction5 and one case each in two kinships from Canada. 6 The gene responsible for MENI was first mapped to chromosome 1 1q137 and subsequently predictive testing using RFLP markers was developed. bronchial carcinoid from a MENI patient has been studied but no loss of heterozygosity was found in the MENI genomic region.'2 Thymic carcinoids, on the other hand, whether sporadic or familial, have never been studied at the molecular level. We report here five affected sibs from a Tasmanian MENI family (Tasman family 2), of whom two were found to have malignant thymic carcinoids. Despite exhaustive genealogy study extending back to the first generation of this kindred in Tasmania, no consanguineous link can be established between this family and the largest reported MENI family in Tasmania.3 Furthermore, the mother of five affected sibs, who died of metastatic glucagonoma, was found to be the oldest member affected ( figure) .
The aims of this study were to determine the region of genetic linkage in Tasman family 2 and thus the feasibility of using MENI linked markers for predictive testing in this family, and to elucidate the genetic defects of MENI related thymic carcinoids.
Subject II.1 was admitted for surgery for primary hyperparathyroidism. Preoperative chest x ray showed a shadow in the anterior mediastinum and CT scan identified a tumour mass arising in the thymus. An infiltrating mass of tumour and metastatic lymph node could not be dissected from the great vessels but were biopsied. Malignant thymic carcinoid was confirmed histologically. Patient II.5 had a history of insulinoma and multiple lipomata and was found to have hypercalcaemia. CT These books of major reviews, two to three years in gestation, are curious beasts. It's heartwarming that people of unquestionable authority are willing to put in so much time and effort for no material reward. The world must be the better for their efforts. But I wonder just how much better it is? How many people on the one hand are ready to spend a day or two digesting the detail but, on the other hand, aren't part of the personal networks by which people active in the field keep themselves informed? I'm reluctant to recommend them to students writing dissertations because most of the benefit to the student is in locating and digesting primary publications. They are good for orienting new postgraduates, with supplemental reading to bring them up to date. They would be good for summarising a field which has reached a milestone: next year would be just right for a major review of Huntington's disease (but this series had one in 1991). Do working scientists read them? Personally I find them too long and too detailed. The much shorter articles in Annual Reviews of Genetics all varieties of mutation discussed, largely around the authors' expertise in blood and how it clots, but extensive appendices provide an anthology of all that is known to ail our species and has been defined at the genomic level. Reading it imposes a pleasant if formidable task on the reviewer. Not only does it excel in clarity but many references, and their discussion, are remarkably recent.
In the treacherous fields of terminology and the word-number interface there are some minor problems worth comment. The diagrams, apparently based on astute use of a spreadsheet package, are very clear, numerous, and well integrated with the text. However, the unnecessary imposition of a third dimension in some does not assist clarity. The computer's expression of chi squared to three places of decimals needs taming. Tuberous sclerosis is now largely split between loci on chromosomes 9 and 16: 11 and 12 have little support, a very recent finding. Harry Harris's operational use of "polymorphism", to cover frequencies exceeding 1%, a reasonable use in the late sixties, is credited to Vogel and Motulsky 20 years later. Ford defined it unambiguously as "the occurrence together in the same locality of two or more discontinuous forms of a species in such proportions that even the rarest of them cannot be maintained merely by mutation". It is now used -or since the word is longer than the neutral term "variant" -misused -so extensively that Ford's useful term, which dominated evolutionary theory for several decades, has died with him, and it is now too late to modify its well established misuse.
Linkage analysis, another casualty of widespread misunderstanding, features as a chapter, and benefits from Clayton's advice. However, the pedigree shown does not need lods as phase is defined and deduction and counting, the appropriate method when phase is clear, are omitted. A few paragraphs on
